Study of hormone refractory prostate cancer: hospital care and palliative care resource use at a VA medical center.
about
Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysisThe lack of standard definitions in the supportive and palliative oncology literatureMelampodium leucanthum, a source of cytotoxic sesquiterpenes with antimitotic activities.Characterising the castration-resistant prostate cancer population: a systematic review.Disparity in hospice utilization by African American patients with cancer.New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?Treatment given near the end of life in castration-resistant prostate cancer.
P2860
Q28533222-96C862F0-6749-487B-984A-B35BC9351B78Q34079747-E722A6F7-AE1A-47DD-8050-B66AB4878541Q36567523-7ED6C149-C4F3-445A-8971-561E7976A7DFQ37945316-7881C1A3-EAA2-4C19-8BF5-8BE443E19B74Q37949329-126D9CAF-97C3-4247-9B3A-D14E99B26197Q39596976-D6129C3D-E8B6-49A5-8873-6F63AB6F517EQ48503121-D988FB4A-34FE-423B-A0CF-B3CC292B02B7
P2860
Study of hormone refractory prostate cancer: hospital care and palliative care resource use at a VA medical center.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Study of hormone refractory pr ...... ce use at a VA medical center.
@en
type
label
Study of hormone refractory pr ...... ce use at a VA medical center.
@en
prefLabel
Study of hormone refractory pr ...... ce use at a VA medical center.
@en
P2093
P2860
P356
P1433
P1476
Study of hormone refractory pr ...... ce use at a VA medical center.
@en
P2093
Basil Kasimis
Janet Cogswell
Shalini Mulaparthi
Shanti Srinivas
Shirley S Hwang
Victor T Chang
Yvette Alejandro
P2860
P304
P356
10.1081/CNV-200039643
P577
2004-01-01T00:00:00Z